The launch makes the country one of the first in the world to back the new R21 vaccine, developed by scientists at Oxford University and made by the Serum Institute of India and Novavax.

From the body of evidence in clinical trials and real-world data, the AstraZeneca-Oxford vaccine has continuously been shown to have an acceptable safety profile and regulators around the world ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.

The necessary sites are confirmed, and we are working closely with Oxford Biomedica (“OXB”), our manufacturing partner, to produce the vaccine product required for study activation. We look forward to ...

Increased capabilities for genomic surveillance have offered new insights into global viral evolution. Seasonal flu showed a 'remarkable' bounce back to pre-pandemic levels once international air ...

A single dose of typhoid conjugate vaccine (TCV) offers safe, effective protection against typhoid two years after vaccination in all children, according to a report by researchers at the Oxford ...

The seasonal flu places a significant burden on healthcare systems globally, leading to over five million hospitalizations ...

The past 12 months have also seen the first deliveries of Oxford’s R21/Matrix-M malaria vaccine in Africa, following a ...

Seasonal influenza epidemics impose substantial burdens on health care systems and cause >5 million hospitalizations of ...

Seasonal influenza epidemics impose substantial burdens on healthcare systems and cause >5 million hospitalizations of adults each year.